Moreover, the result of a recent study that nucleotide reverse transcriptase inhibitors can improve insulin sensitivity and reduce the development of type 2 diabetes supports the relationship between the development of type II diabetes mellitus and CNVs extension as well (Ambati et al., 2020). This evidence concerns the gene INS and type 2 diabetes mellitus.